Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003125
Disease: Anorexia Nervosa
Anorexia Nervosa
0.010 AlteredExpression disease BEFREE Protein expression in PBMCs of cyclooxygenase-2 (COX-2) and the activated forms of the mitogen-activated protein kinases p38 and ERK were also increased in the AN group. 31398429 2020
CUI: C0005283
Disease: beta Thalassemia
beta Thalassemia
0.010 AlteredExpression disease BEFREE Oridonin enhances γ‑globin expression in erythroid precursors from patients with β‑thalassemia via activation of p38 MAPK signaling. 31789406 2020
CUI: C0022354
Disease: Jaundice, Obstructive
Jaundice, Obstructive
0.010 AlteredExpression disease BEFREE All these data demonstrated that p38 MAPK-pHsp27 mediates vascular hyporesponsiveness in rats with obstructive jaundice by modulating the expression level of pHsp27 and F-actin, and that inhibition of p38 MAPK signaling could remodel the vascular activity. 31810142 2020
CUI: C0035334
Disease: Retinitis Pigmentosa
Retinitis Pigmentosa
0.010 Biomarker disease BEFREE The mechanism might be related to inhibit the activation of P38 pathway.<b>Conclusions:</b> This study showed the beneficial effects of DHAG, a compound possessing antioxidant properties, and provided scientific rationale to develop DHAG as a potential agent to treat RP. 31648555 2020
CUI: C0037286
Disease: Skin Neoplasms
Skin Neoplasms
0.010 Biomarker group BEFREE Hyperoside markedly inhibited diffuse epidermal hyperplasia and significantly reduced the changes in phosphorylated levels of PI3K, AKT, mTOR and AMPK while reducing p38 phosphorylation as well as of tumor burden <i>in vivo</i> in DMBA/TPA induced skin tumors. 31585897 2020
CUI: C0858004
Disease: Influenza A virus infection
Influenza A virus infection
0.010 AlteredExpression disease BEFREE In this study, we demonstrated that p38 MAPK-mediated matrix metalloproteinase-13 expression by influenza A virus infection led to destabilization of vulnerable atherosclerotic plaques in artery.(191 words). 31693113 2020
CUI: C0940937
Disease: precancerous lesions
precancerous lesions
0.010 Biomarker phenotype BEFREE DFMO was also found to suppress the development of esophageal precancerous lesions in an NMBA-induced rat model; IHC demonstrated p38 α, ERK1/2, and AKT/mTOR/p70S6K pathways to be downregulated in these rats. 31793679 2020
CUI: C2062441
Disease: Influenza A
Influenza A
0.010 AlteredExpression disease BEFREE Furthermore, the expression of matrix metalloproteinase-13 was regulated by influenza A virus through activation of the p38 MAPK signal pathway. 31693113 2020
CUI: C3841475
Disease: beta^+^ Thalassemia
beta^+^ Thalassemia
0.010 AlteredExpression disease BEFREE Oridonin enhances γ‑globin expression in erythroid precursors from patients with β‑thalassemia via activation of p38 MAPK signaling. 31789406 2020
CUI: C4049446
Disease: Neointimal hyperplasia
Neointimal hyperplasia
0.010 GeneticVariation disease BEFREE Though homozygous deletion of Poldip2 is lethal, heterozygous mice are viable and show protection against aneurysm and injury-induced neointimal hyperplasia, diseases linked to loss of VSMC differentiation. 31656131 2020
CUI: C4546431
Disease: Exacerbation of allergic asthma
Exacerbation of allergic asthma
0.010 Biomarker disease BEFREE Blocking TRPV4or p38 MAPK using HC-067047 and SB203580 respectively, effectively alleviated the exacerbation of allergic asthma induced by this simultaneous exposure to formaldehyde and high relative humidity. 31662264 2020
CUI: C0001857
Disease: AIDS related complex
AIDS related complex
0.010 AlteredExpression disease BEFREE Taken together, our results implied that the elevated LMα4, which was possibly caused by the decreased MMP-9, increased TGF-β1 and activated p38 MAPK signaling during senescence, leading to the development of ARC. 31076560 2019
CUI: C0002895
Disease: Anemia, Sickle Cell
Anemia, Sickle Cell
0.010 Biomarker disease BEFREE <b>Materials and methods:</b> Humanized mouse model with SCD defined as moderate- and non-responders to EA were intraperitoneally administered with antagonist of SP receptor NK1R (netupitant, 10 mg/kg/day, i.p.) or p38 MAPK inhibitor (SB203580, 10 mg/kg/day, i.p.) alone or in combination with EA (acupoint GB30, every 3rd day until day 12). 31447579 2019
CUI: C0008055
Disease: Chikungunya Fever
Chikungunya Fever
0.010 Biomarker disease BEFREE A strong polar interaction was predicted between Thr-180 (within the phosphorylation lip) of p38 and Gln-273 of nsP2, whereas, no such polar interaction was predicted for the phosphorylation lip of JNK which indicates the differential roles of p-p38 and p-JNK during CHIKV infection in the host macrophages. 31031770 2019
CUI: C0014869
Disease: Peptic Esophagitis
Peptic Esophagitis
0.010 Biomarker disease BEFREE Additionally, treatment with isorhamnetin inhibited p38 MAPK and NFκB activation in RE esophagus. 31586635 2019
CUI: C0015672
Disease: Fatigue
Fatigue
0.010 Biomarker phenotype BEFREE Our findings identify that penfluridol acts as an inducer of ER stress and p38 MAPK activation, which led to UPR-mediated nonapoptotic cell death via autophagosome accumulation-caused energy loss. 31308361 2019
CUI: C0015923
Disease: Fetal Alcohol Syndrome
Fetal Alcohol Syndrome
0.010 Biomarker disease BEFREE Our study supplies the evidence supporting the molecular mechanism by which ropivacaine activates the MAPK/p38/Fas signal to promote neurogliocyte apoptosis and suggests that the combination of p38 inhibitor with ropivacaine might be an effective strategy to decrease the ropivacaine-caused neurogliotoxicity. 31028842 2019
CUI: C0017661
Disease: IGA Glomerulonephritis
IGA Glomerulonephritis
0.010 AlteredExpression disease BEFREE Assessment of kidney biopsy specimens from IgA nephropathy patients revealed that the degree of interstitial fibrosis was significantly associated with the tissue immunoactivity of phosphorylated p38. 30897126 2019
CUI: C0018378
Disease: Guillain-Barre Syndrome
Guillain-Barre Syndrome
0.010 AlteredExpression disease BEFREE GBS infection increased levels of total and phosphorylated mitogen-activated protein kinase (MAPK) family members such as p38 and JNK and induced nuclear factor kappa B (NF-κB) pathway activation. 31548323 2019
CUI: C0019061
Disease: Hemolytic-Uremic Syndrome
Hemolytic-Uremic Syndrome
0.010 Biomarker disease BEFREE Enterohemorrhagic <i>Escherichia coli</i> (EHEC) is a pathological strain that can induce mitogen-activated protein (MAP) kinase (Erk, Jnk and p38 MAPK) and NF-κB pathway activation and proinflammatory cytokine production, which then causes diarrheal diseases such as hemorrhagic colitis and hemolytic uremic syndrome. 31130074 2019
CUI: C0020473
Disease: Hyperlipidemia
Hyperlipidemia
0.010 AlteredExpression disease BEFREE Hyperlipidemia enhanced the expression of p-MLC and MLCK, which were associated with the increased phosphorylation of ERK, p38 and JNK. 30651770 2019
CUI: C0021051
Disease: Immunologic Deficiency Syndromes
Immunologic Deficiency Syndromes
0.010 AlteredExpression group BEFREE By contrast, downregulation of p38 MAPK by SB203580 enhanced expression of HO-1 and iNOS and decreased migration of leukemic cells in vitro and their seeding efficiency to vital organs in vivo after injection into immunodeficient mice. 30302660 2019
CUI: C0021364
Disease: Male infertility
Male infertility
0.010 AlteredExpression phenotype BEFREE Therefore, these results demonstrate that inhibition of p38 activity prevents CdCl<sub>2</sub>-induced apoptotic GC-2spd cell death by reducing depolarization of mitochondrial membrane potential and mitochondrial ROS levels via ERK phosphorylation in a signal pathway different from the CdCl<sub>2</sub>-induced ERK/Drp1/p38 axis and suggest a therapeutic strategy for CdCl<sub>2</sub>-induced male infertility. 31676320 2019
CUI: C0026948
Disease: Mycosis Fungoides
Mycosis Fungoides
0.010 Biomarker group BEFREE Our work provided direct evidences for effects of SHARPIN on JNKs and NF-κB pathway, and the contributing roles of JNKs, NF-κB and p38 pathway regulated by SHARPIN in the development of MF. 31461795 2019
CUI: C0027059
Disease: Myocarditis
Myocarditis
0.010 Biomarker disease BEFREE <i>Scutellaria baicalensis</i> Inhibits Coxsackievirus B3-Induced Myocarditis Via AKT and p38 Pathways. 31370111 2019